¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"time study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
single blind study
´ÜÀϸͰ˿¬±¸
urodynamic study
¿ä¿ªµ¿Çа˻ç
video-urodynamic study
¿µ»ó¿ä¿ªµ¿Çа˻ç
arm-to-retina circulation time
ÆÈ¸Á¸·¼øÈ¯½Ã°£
atrioventricular conduction time
¹æ½ÇÀüµµ½Ã°£
acquisition time
ȹµæ½Ã°£
activated coagulation time
Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
activated partial thromboplastin time
Ȱ¼ºÈºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
bleeding time
ÃâÇ÷½Ã°£
bleeding time test
ÃâÇ÷½Ã°£°Ë»ç
breath holding time
¼ûÂü´Â½Ã°£, È£ÈíÁßÁö½Ã°£
circulation time
¼øÈ¯½Ã°£
clot retraction time
ÇǶ±µÞ´ç±è½Ã°£, Ç÷º´¼öÃà½Ã°£
clotting time
ÀÀ°í½Ã°£
coagulation time
ÀÀ°í½Ã°£
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
inspiratory pause time
µé¼ûÈĽ¬´Â½Ã°£, Èí±âÈÄÈÞÁö½Ã°£
inspiratory phase time
µé¼û½Ã°£, Èí±â½Ã°£
latent time
Àẹ½Ã°£
maximum phonation time
ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
mean survival time
Æò±Õ»ýÁ¸½Ã°£
partial thromboplastin time
ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
prothrombin time
ÇÁ·ÎÆ®·Òºó½Ã°£
reaction time
¹ÝÀÀ½Ã°£
recovery time
ȸº¹½Ã°£
repetition time
¹Ýº¹½Ã°£
scrub time
¼Õ¾Ä´Â½Ã°£
survival time
»ýÁ¸±â°£
thrombin time
Æ®·Òºó½Ã°£
transit time
ÀüÀ̽ð£, Åë°ú½Ã°£
voiding time
¹è´¢½Ã°£
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
population study
Àα¸Á¶»ç
preclinical study
ÀÓ»óÀü½ÃÇè
pressure flow study
¾Ð·Â¿ä·ù°Ë»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
professional activity study
Àü¹®°¡È°µ¿¿¬±¸
prospective study
°èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸
retrospective study
ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
study
¿¬±¸, °Ë»ç
single blind study
´ÜÀϸͰ˹ý
survivorship study
»ýÁ¸¿¬±¸
tracer study
ÃßÀûÀÚ¿¬±¸
urodynamic study
¿ä¿ªµ¿Çа˻ç
video-urodynamic study
¿µ»ó¿ä¿ªµ¿Çа˻ç
water-loading study
¼öºÐºÎÇÏ¿¬±¸
acquisition time
ȹµæ½Ã°£
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
activated partial thromboplastin time
Ȱ¼º ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
activated partial thromboplastin time =aPTT
Ȱ¼ºÈ ºÎºÐ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ ½Ã°£
appearance time
ÃâÇö½Ã°£(õóúÞãÁÊà) ¼øÈ¯(âàü») .
area under the concentration-time curve : AUC
Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
arm to tongue time test
ÆÈÇô¼øÈ¯½Ã°£½ÃÇè
arm-to-retina circulation time
ÆÈ¸Á¸·¼øÈ¯½Ã°£, ¿Ï-¸Á¸·¼øÈ¯½Ã°£
gastric emptying time
À§(êÖ)(³»¿ë(Ò®é»))¹èÃâ½Ã°£(ÛÉõóãÁÊà).
gastric emptying time
À§(³»¿ë)¹èÃâ½Ã°£.
generation time =doubling t.
¼¼´ë½Ã°£(á¦ÓÛãÁÊà), ¹èÀ§½Ã°£(ÛÃêÈãÁÊà), ¼¼´ë±â(á¦ÓÛÑ¢).
half survival time
¹Ý°¨ÀÜ»ý¼ö¸í(ËÑ˧ ËÛËÎ).
half survival time
¹Ý°¨ÀÜ»ý¼ö¸í(ÚâÊõíÑßæáøÙ¤).
half time for saturation
¹ÝÆ÷ȱâ(ÚâøéûúÑ¢).
hardening time
°æÈ½Ã°£(¡ãÁÊà).
inertia time
Ÿ¼º½Ã°£(öçàõãÁÊà)
influx time
À¯ÀԽð£(êüìýãÁÊà).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
validity of clinical study
video-urodynamic study
ºñµ¥¿À ¿ä¿ªÇа˻ç
water-loading study
¼öºÐ-ºÎÇÏ ½ÃÇè
acquisition time
ȹµæ ½Ã°£
activated clotting time
Ȱ¼ºÈÀÀ°í½Ã°£
activated coagulation time(ACT)
Ȱ¼º Ç÷¾× ÀÀ°í½Ã°£
activated coagulation time=ACT
Ȱ¼ºÈ ÀÀ°í½Ã°£
activated partial prothrombin time
Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
activated partial thromboplastin time
Ȱ¼º ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
activated partial thromboplastin time =aPTT
Ȱ¼ºÈ ºÎºÐ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ ½Ã°£
appearance time
ÃâÇö½Ã°£(õóúÞãÁÊà) ¼øÈ¯(âàü») .
area under the concentration-time curve : AUC
Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
arm to tongue time test
ÆÈÇô¼øÈ¯½Ã°£½ÃÇè
arm-to-retina circulation time
ÆÈ¸Á¸·¼øÈ¯½Ã°£, ¿Ï-¸Á¸·¼øÈ¯½Ã°£
association time
¿¬»ó½Ã°£(æáßÌãÁÊà)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½